May 22, 2008

07:00 Registration

08:20 SSIF Welcome and Introduction

Session I 

Background of the disease

08:30 Chairman’s Introduction:  
M. A. Gurer, Turkey -  A. Katsambas, Greece

08:40 Epidemiology and genetics of psoriasis
N. İlter, Turkey

09:00 Psoriasis: A brief history of disease management
T. Ergun, Turkey

09:20 Use of traditional systemic therapies for moderate to severe psoriasis
J.L. Pace, Malta

09:50 Why are new therapies needed for psoriasis management
Speaker TBC

10:10 Discussion

10:20 Coffee break

Session II 

Mechanism of action and update on clinical trial outcomes

10:40 New learnings on the immunological basis for psoriasis
N. Atakan, Turkey

11:00 TNF-blockers: Etanercept, infliximab & adalimumab
C. Pincelli, Italy

11:45 T-cell modulators: Alefacept and efalizumab
A. Katsambas, Greece

12:30 Discussion

12:40 Lunch

Session III 

A step ahead in the psoriasis management

13:40 Patient needs and patient support
N. Onsun, Turkey

14:00 The ideal therapy for psoriasis (case studies)
C. E. M. Griffiths, United Kingdom

14:20 An overview: Safety and efficacy of biologicals
K. Papp, Canada

15:20 Discussion

15:30 Closing remarks